方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 克罗恩病活动指数× | Harvey-Bradshaw指数× | |
|---|---|---|
| 领域 | 胃肠病学 | 胃肠病学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1976 | 1980 |
| 提出者≠ | Best, W. R., Becktel, J. M., Singleton, J. W., and Kern, F. | R. F. Harvey and J. M. Bradshaw |
| 类型 | Clinician-rated | Clinician-rated |
| 开创性文献≠ | Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976). Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology, 70(3), 439–444. DOI ↗ | Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn's-disease activity. Lancet, 315(8167), 514. DOI ↗ |
| 别名 | CDAI | HBI |
| 相关≠ | 4 | 5 |
| 摘要≠ | The Crohn's Disease Activity Index (CDAI) is a comprehensive, weighted index for assessing disease activity in Crohn's disease. Developed in 1976 by Best and colleagues for the National Cooperative Crohn's Disease Study, the CDAI integrates eight clinical and laboratory variables into a single score ranging from <150 (remission) to >450 (severe activity). Although more complex than symptom-based tools, the CDAI captures the multidimensional nature of Crohn's disease and remains the reference standard for severe disease assessment. | The Harvey-Bradshaw Index (HBI) is a simple, clinician-administered tool for assessing disease activity in Crohn's disease. Developed in 1980, it measures five clinical parameters including abdominal pain, stool frequency, and extraintestinal manifestations. The HBI is widely used in clinical practice and research for monitoring disease progression and treatment response. |
| ScholarGate数据集 ↗ |
|
|